Johnson & Johnson Reportedly Pauses COVID Vaccine Production, Raising Vaccine Access Issues
In the United States, the US Centers for Disease Control and Prevention has advisable Pfizer’s and Moderna’s vaccines over Johnson & Johnson’s for most people, citing considerations over a uncommon however dangerous blood-clotting disorder seen with J&J, and since the other two vaccines are widely accessible and accessible now within the US. Some health officials …